NephroGenex, Inc. 4
4 · NephroGenex, Inc. · Filed May 4, 2015
Insider Transaction Report
Form 4
Mitchum James P.
Director
Transactions
- Award
Options to Purchase Common Stock
2015-04-30+13,740→ 13,740 totalExercise: $7.31From: 2016-04-30Exp: 2025-04-30→ Common Stock (13,740 underlying)
Footnotes (1)
- [F1]All shares underlying the options will vest on April 30, 2016 and expire 10 years from issuance.